Early stage NSCLC

78P - Lung resection for cancer in patients with heart disease: Management and postoperative outcome

Authors
  • F. Caushi (Tirana, Albania)
  • I. Skenduli (Tirana, Albania)
  • A. Hatibi (Tirana, Albania)
  • A. Mezini (Tirana, Albania)
  • S. Telo (Tirana, Albania)
  • S. Bala (Tirana, Albania)
  • E. Shima (Tirana, Albania)
  • A. Cani (Tirana, Albania)
Speakers
  • F. Caushi (Tirana, Albania)

Previous ePoster
59P - Comparison of internal target volume delineation using CT datasets of four-dimensional computed tomography in lung cancer radiotherapy

Next ePosters
199P - Safety meta-analysis of clinical trials delivering TTFields to the upper torso
79P - Tissue microarray analysis on prognostic value of coexpression of RUNX3 and trimethylated histone H3 lysine 27 in surgically resected patients with stage I non-small cell lung cancer
180TiP - An open-label, randomized, phase I/II trial of IO102 and pembrolizumab, or IO102, pembrolizumab and chemotherapy, as first-line treatment for patients with metastatic non-small cell lung cancer
No ePoster preview available
15P - TTF1 status in non-small cell lung cancer adenocarcinoma: A prognostic factor
No ePoster preview available
80P - High blood platelets levels (BPL): A prognostic factor in patients with early or locally advanced non-small cell lung cancer (NSCLC)
169P_PR - Benefit of immunotherapy (IT) in advanced non-small cell lung cancer (NSCLC) in elderly patients (EP)
73P - Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries
31P - Do two lungs form an integrated immune system? Learning from BALF examination in lung cancer
36P - Can a BALF profile distinguish hot vs cold lung tumors?
8P - Role of chemokines in resectable non-small cell lung cancer (NSCLC)